1. Home
  2. RCON vs IGC Comparison

RCON vs IGC Comparison

Compare RCON & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recon Technology Ltd.

RCON

Recon Technology Ltd.

HOLD

Current Price

$1.24

Market Cap

41.3M

Sector

Energy

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.32

Market Cap

33.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCON
IGC
Founded
2007
2005
Country
China
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3M
33.8M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
RCON
IGC
Price
$1.24
$0.32
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
20.1K
626.1K
Earning Date
10-14-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,252,775.00
$1,106,000.00
Revenue This Year
N/A
$3.54
Revenue Next Year
N/A
$15.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$0.25
52 Week High
$7.16
$0.50

Technical Indicators

Market Signals
Indicator
RCON
IGC
Relative Strength Index (RSI) 40.57 30.14
Support Level $1.13 $0.31
Resistance Level $1.36 $0.34
Average True Range (ATR) 0.09 0.02
MACD 0.02 -0.00
Stochastic Oscillator 61.29 10.73

Price Performance

Historical Comparison
RCON
IGC

About RCON Recon Technology Ltd.

Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: